When is Dakshidin’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Dakshidin’s earnings last quarter?
Dakshidin released its earnings results on Sep 26, 2019. The company reported $0 earnings per share for the quarter.
Is Dakshidin overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Dakshidin pay dividends?
Dakshidin does not currently pay dividends.
What is Dakshidin’s EPS estimate?
Dakshidin’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Dakshidin have?
Dakshidin has 5,000,000,000 shares outstanding.
What happened to Dakshidin’s price movement after its last earnings report?
Dakshidin reported an EPS of $0 in its last earnings report. Following the earnings report the stock price went same ―.
Which hedge fund is a major shareholder of Dakshidin?
Currently, no hedge funds are holding shares in DKSC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Dakshidin
Dakshidin Corporation, Inc., through its subsidiaries, operates as a CBD/cannabis-based medical product company. It cultivates cannabis; and operates an online sales portal for CBD products. The company also manages distribution channel programs in the retail distribution, reselling, and direct sales market segments. Dakshidin Corporation, Inc. was formerly known as Avrada, Inc. and changed its name to Dakshidin Corporation, Inc. in February 2007. The company is based in Miami, Florida with additional offices in Las Vegas, Nevada.